Skip to main content

What the FDA labels say about taking them together

Clozapine and fosphenytoin

Fosphenytoin's FDA label of May 18, 2025 names clozapine in its drug interactions section; the clozapine labels PlainMeds reads (2) do not name fosphenytoin. The fosphenytoin label: “Interacting Agent: Other; Examples: Albendazole, chlorpropamide, clozapine, cyclosporine, digoxin, disopyramide, folic acid, methadone, mexiletine, praziquantel, quetiapine”

Check it at the source: the clozapine FDA label on DailyMed (effective June 6, 2025, HLS Therapeutics (USA), Inc.); the fosphenytoin FDA label on DailyMed (effective May 18, 2025, Pfizer Laboratories Div Pfizer Inc).

What does the clozapine label say about fosphenytoin?

Clozapine's label (effective June 6, 2025) and its 1 other brand-application label do not name fosphenytoin in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Clozaril), NDA019758 (Heritage Life), as published by HLS Therapeutics (USA), Inc., effective June 6, 2025 (SPL set 90876802-0e3a-44c9-9ff7-1754dfbe736a), via openFDA; the full label on DailyMed

What does the fosphenytoin label say about clozapine?

Fosphenytoin label, drug interactions

Interacting Agent: Other; Examples: Albendazole (decreases active metabolite), chlorpropamide, clozapine, cyclosporine, digoxin, disopyramide, folic acid, methadone, mexiletine, praziquantel, quetiapine

Source: FDA drug label (CEREBYX), NDA020450 (Parke Davis), as published by Pfizer Laboratories Div Pfizer Inc, effective May 18, 2025 (SPL set de5a6711-4abb-4c3d-a18b-266b094ace11), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

11Clozapine generic labelers
7Fosphenytoin generic labelers
ClozapineFosphenytoin
Labeled forSchizophreniaSeizures and epilepsy
Boxed warningYesYes
Pharmacy cost (NADAC)$0.610 per tablet 100 mg tabletn/a
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?